The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes

The efficacy and safety of once‐weekly dulaglutide 0.75 mg (dulaglutide) in Japanese patients with type 2 diabetes (T2D) were evaluated according to subgroups defined by concomitant oral hypoglycaemic agents. This exploratory analysis included data from a randomized, open‐label, phase III study that...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Nobuya, Araki, Eiichi, Oura, Tomonori, Matsui, Akiko, Takeuchi, Masakazu, Tanizawa, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129571/
https://www.ncbi.nlm.nih.gov/pubmed/27488246
http://dx.doi.org/10.1111/dom.12758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129571/
https://www.ncbi.nlm.nih.gov/pubmed/27488246
http://dx.doi.org/10.1111/dom.12758

Ejemplares similares